The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

A team of scientists has found new clues that could change how we think about aging. Their work suggests that aging might not ...

The prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Eli Lilly's Mounjaro, a new diabetes and weight loss drug, is making waves in India. Approved by the drug regulator, this ...

An A1C test is a blood draw used to diagnose and manage prediabetes and diabetes. Learn more about who needs this test and ...

Alongside this research, other studies have shown that lifestyle choices can also help manage diabetes. Eating more whole ...

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Research reveals a hidden connection between diabetes and cancer. Learn how your blood sugar levels might impact your long-term health.